Back to search

Article

Novel Prognostic Score for Recurrent or Metastatic Head and Neck Cancer Patients treated with Nivolumab: Japanese Multi-Institutional Cohort Study

2021-06-03

Abstract excerpt

Although several prognostic factors in nivolumab therapy have been reported in patients with recurrent or metastatic head and neck cancer (RM-HNC), these factors remain controversial. Here, we conducted a multicenter retrospective cohort study to investigate the impact of clinico-hematological factors on survival in RM-HNC patients treated with nivolumab. We retrospectively reviewed 126 RM-HNC patients from seven...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
12089b02-c745-52d2-a829-0f4f088cf4e3
DOI
10.21203/rs.3.rs-576295/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Novel Prognostic Score for Recurrent or Metastatic Head and Neck Cancer Patients treated with Nivolumab: Japanese Multi-Institutional Cohort StudyDOI 10.21203/rs.3.rs-576295/v1
A Systematic Review on a comprehensive evaluation of clinical prognostic variables and new biomarkers for head and neck cancer outcomeSemantic proximity
The Neutrophil-to-Lymphocyte Ratio as a Prognostic Indicator in Head and Neck Cancer: A Systematic Review and Meta-AnalysisSemantic proximity
Immunotherapy with PD-1 Inhibitor Nivolumab in Recurrent/Metastatic Platinum Refractory Head and Neck Cancers: The Early Experience of Two Academic CenterSemantic proximity
External validation of prognostic and predictive gene signatures in head and neck cancer patientsSemantic proximity
Establishment of an integrated model for predicting survival and guiding treatment in local recurrence nasopharyngeal carcinomaSemantic proximity
Clinicopathological and molecular features of responders to nivolumab for patients with advanced gastric cancerSemantic proximity
Analysis of high-risk factors and prognosis of early relapse in 104 patients with natural killer/T-cell lymphoma: a single-center retrospective studySemantic proximity
Association Between Genetic Variants and the Risk of Nivolumab-Induced Immune-Related Adverse EventsSemantic proximity
Risk Stratification and Individualized Chemotherapy for Elderly Patients with Locoregionally Advanced Nasopharyngeal CarcinomaSemantic proximity
Immunological Status May Predict Response to Nivolumab in Non-small Cell Lung Cancer without Driver Mutations.Semantic proximity
Prognostic value of circulating Epstein-Barr virus DNA level post-induction chemotherapy for patients with nasopharyngeal carcinoma: A recursive partitioning risk stratification analysisSemantic proximity
Expression of chemokine CXCL8/9/10/11/13 and its prognostic significance in head and neck cancerSemantic proximity
Select a neighboring publication to make it the new centre.